Drug intelligence / Profile preview

Shenrong Weisheng Pill

Development stage: Unknown
Lead developer: Universe Pharmaceuticals
Administration: Oral

Overview

**Shenrong Weisheng Pill** is a traditional Chinese medicine derivative (TCMD) product manufactured by Universe Pharmaceuticals INC, designed for the treatment and relief of common chronic health conditions in the elderly to promote physical wellness and longevity. It belongs to the category of chronic condition treatments, targeting issues such as fatigue, qi and blood deficiency, and related symptoms including exhaustion, lusterless complexion, limb stagnation, bone and flesh ache, and weak pulse. As a pill formulation, it is part of Universe Pharmaceuticals' portfolio of 13 TCMD products approved by China's National Medical Products Administration (NMPA) and distributed across approximately 202 cities in 30 provinces.[2][3][10]

Brand names: Shenrong Weisheng Pill
Other names: Shenrong Weisheng

Beyond the preview

Go deeper on Shenrong Weisheng Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenrong Weisheng Pill.

Explore the full profile